These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9562511)

  • 21. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.
    Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL
    Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated protein C resistance caused by factor V gene mutation: common coagulation defect in chronic venous leg ulcers?
    Peus D; Heit JA; Pittelkow MR
    J Am Acad Dermatol; 1997 Apr; 36(4):616-20. PubMed ID: 9092749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central retinal vein thrombosis associated with resistance to activated protein C.
    Dhôte R; Bachmeyer C; Horellou MH; Toulon P; Christoforov B
    Am J Ophthalmol; 1995 Sep; 120(3):388-9. PubMed ID: 7661212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Activated protein C resistance in factor V disease: how high is the risk of thrombosis?].
    Spannagl M; Schramm W
    Dtsch Med Wochenschr; 1998 Feb; 123(6):137-9. PubMed ID: 9505951
    [No Abstract]   [Full Text] [Related]  

  • 27. Factor V gene mutation causing inherited resistance to activated protein C as a basis for venous thromboembolism.
    Dahlbäck B
    J Intern Med; 1995 Mar; 237(3):221-7. PubMed ID: 7891043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resistance to activated protein C and Arg 506 Gln factor V mutation are uncommon in eastern Asian populations.
    Kodaira H; Ishida F; Shimodaira S; Takamiya O; Furihata K; Kitano K
    Acta Haematol; 1997; 98(1):22-5. PubMed ID: 9210909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activated protein C resistance: the commonest hereditary hypercoagulation disorder.
    Khogali I; Summerfield GP; Mudawi A
    Br J Surg; 1998 Aug; 85(8):1160; author reply 1161. PubMed ID: 9718028
    [No Abstract]   [Full Text] [Related]  

  • 30. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis.
    Zöller B; Hillarp A; Berntorp E; Dahlbäck B
    Annu Rev Med; 1997; 48():45-58. PubMed ID: 9046944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factor V Leiden mutation in a case with ischemic stroke: which relationship? A case report.
    Orlandi G; Pellegrinetti A; Fioretti C; Martini A; Murri L
    Angiology; 1998 Jan; 49(1):79-82. PubMed ID: 9456169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudo-homozygous activated protein C resistance due to coinheritance of heterozygous factor V Leiden mutation and type I factor V deficiency. Variable expression when analyzed by different activated protein C resistance functional assays.
    Delahousse B; Iochmann S; Pouplard C; Fimbel B; Charbonnier B; Gruel Y
    Blood Coagul Fibrinolysis; 1997 Nov; 8(8):503-9. PubMed ID: 9491268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
    Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
    J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated protein C resistance as a "new" cause of deep venous thrombosis in aviators.
    Emonson DL
    Aviat Space Environ Med; 1997 Jul; 68(7):606-8. PubMed ID: 9215466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-segregation of thrombosis with the factor V Q506 mutation in an extended family with resistance to activated protein C.
    Beufé S; Borg JY; Vasse M; Charbonnier F; Moreau V; Monconduit M; Frebourg T
    Br J Haematol; 1995 Mar; 89(3):659-62. PubMed ID: 7734374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular detection of a common mutation in coagulation factor V causing thrombosis via hereditary resistance to activated protein C.
    Liu XY; Nelson D; Grant C; Morthland V; Goodnight SH; Press RD
    Diagn Mol Pathol; 1995 Sep; 4(3):191-7. PubMed ID: 7493138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resistance to activated protein C in unselected patients with arterial and venous thrombosis.
    Faioni EM; Razzari C; Martinelli I; Panzeri D; Franchi F; Mannucci PM
    Am J Hematol; 1997 Jun; 55(2):59-64. PubMed ID: 9208999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial and venous thrombosis in two Italian families with the factor V Arg506-->Gln mutation.
    Montaruli B; Voorberg J; Tamponi G; Borchiellini A; Muleo G; Pannocchia A; van Mourik JA; Schinco P
    Eur J Haematol; 1996 Jul; 57(1):96-100. PubMed ID: 8698138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited thrombotic disorders: an update.
    Florell SR; Rodgers GM
    Am J Hematol; 1997 Jan; 54(1):53-60. PubMed ID: 8980261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.